Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene

被引:12
|
作者
Liang, HL [1 ]
Lunec, J [1 ]
机构
[1] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
MDM2; p53; promoter;
D O I
10.1016/j.gene.2005.07.018
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The MDM2 oncogene exhibits a complex expression pattern partly due to the usage of multiple promoters. Two MDM2 promoters (PI and P2) have been identified. P1 is located upstream of exon 1 and is modulated by PTEN. P2 sits in intron 1 and is activated by p53. Here we report the discovery of a third promoter (designated P3) in intron 3 of this gene, which contains a TATA-box element and p53DNA-binding sequences. DNA-protein binding assays indicated that p53 bound to this region specifically. This region also demonstrated promoter activity in a reporter gene system, which was down-regulated by p53. Furthermore, experiments combining P2 and P3 in the same reporter construct indicated that P3 had a suppressive effect on P2 at high levels of p53. These results suggest that one of the P3 functions is to dampen the expression of MDM2 at high levels of p53, adding an additional element to the feedback loop between p53 and MDM2. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 50 条
  • [41] mdm2/p53与肿瘤
    金永丽
    王靖华
    陈龙邦
    临床肿瘤学杂志, 2007, (06) : 469 - 471
  • [42] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    Nature, 1997, 387 : 299 - 303
  • [43] Mdm2: p53's lifesaver?
    Shmueli, Ayelet
    Oren, Moshe
    MOLECULAR CELL, 2007, 25 (06) : 794 - 796
  • [44] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [45] Interaction between gene p53 and oncogene mdm2 in human glandularlung cancer cellline GLC82
    李萍
    饶国洲
    陈迎春
    丁振若
    于文彬
    Chinese Medical Journal, 1999, (09)
  • [46] The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas
    Calogero, A
    Arcella, A
    De Gregorio, G
    Porcellini, A
    Mercola, D
    Liu, CT
    Lombari, V
    Zani, M
    Giannini, G
    Gagliardi, FM
    Caruso, R
    Gulino, A
    Frati, L
    Ragona, G
    CLINICAL CANCER RESEARCH, 2001, 7 (09) : 2788 - 2796
  • [47] Interaction between gene p53 and oncogene mdm2 in human glandularlung cancer cellline GLC82
    李萍
    饶国洲
    陈迎春
    丁振若
    于文彬
    中华医学杂志(英文版), 1999, (09) : 82 - 85
  • [48] Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas
    Mark J. Pykett
    John Landers
    Donna L. George
    Journal of Neuro-Oncology, 1997, 32 : 39 - 44
  • [49] ABNORMALITIES OF THE P53 MDM2 AND DCC GENES IN HUMAN LEIOMYOSARCOMAS
    PATTERSON, H
    GILL, S
    FISHER, C
    LAW, MG
    JAYATILAKE, H
    FLETCHER, CDM
    THOMAS, M
    GRIMER, R
    GUSTERSON, BA
    COOPER, CS
    BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1052 - 1058
  • [50] Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops
    Cheng, Tzu-Hao
    Cohen, Stanley N.
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (01) : 111 - 119